Coronavirus is spreading across the United States more widely than it did in previous waves. U.S. hospitalizations rose 40 percent in the past month and increased across 38 states during the past week. The country saw more than 75,000 new…
By Lauran Neergaard, Matthew Perrone, Associated Press
With vaccines against COVID-19 inching closer, U.S. regulators took an unusual step Thursday in asking outside scientists: Are the government's standards high enough to adequately judge the shots?…
By Mauricio Savarese, Associated Press
Brazilian President Jair Bolsonaro overruled his own health minister on Wednesday, rejecting the announced purchase of 46 million doses of CoronaVac, a potential vaccine against COVID-19 being tested in Sao Paulo state.
By Laura Santhanam
Health Secretary Alex Azar will meeting with Dr. Robert Redfield, who directs the Centers for Disease Control and Prevention, to update the public about progress in the nation's COVID-19 response and its pursuit of a vaccine.
By Danica Kirka, Associated Press
U.K. researchers are preparing to infect healthy young volunteers with the virus that causes COVID-19, becoming the first scientists to use the controversial technique to study the disease and potentially speed up development of a vaccine.
The United States’ experience with the coronavirus pandemic has been marked by misinformation and disagreement. What do we know for sure about the risks of COVID-19 -- and where incorrect information is originating? Former CDC director Tom Frieden of Resolve…
By Zeke Miller, Matthew Perrone, Associated Press
In briefing documents posted on its website, the FDA said vaccine makers should follow trial participants for at least two months to rule out safety issues before seeking emergency approval.
By Carla K. Johnson, Associated Press
A U.S. advisory panel is making recommendations for who should be first in line to get COVID-19 vaccine.
By Associated Press
Fauci says several kinds of vaccines are in final-stage testing in the U.S. A single-dose candidate is the most recent trial, which requires thousands of volunteers.
By Linda A. Johnson, Associated Press
Johnson & Johnson is beginning a huge final-stage study to try to prove if a single-dose COVID-19 vaccine can protect against the virus.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.